Clinical Study
Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis
Table 3
Outcome after LT for diffuse splanchnic venous thrombosis.
| | | Pat 1 | Pat 2 | Patient 3 | Pat 4 | Pat 5 |
| | IS | TAC | TAC | TAC | TAC | TAC |
| | Re-LT | No | No | No | No | Yes (PNF) |
| Post-LT
surgery | Splenectomy, gastric devascularization
Redo Roux-YHJ | — | d1:bleed
d32
evisceration
d43 parietal prosthesis | splenectomy, and gastric devascularization and
Roux-Y HJ | d1:bleed
Roux-YHJ
parietal prosthesis
d11:HA thrombectomy |
| | Indication reoperation | GI bleed from
varix at HJ | — | bleed
parietal infect | GI bleed
from varices | bleed
allograft failure |
| | Acute rejection | No | No | No | No | No |
| | Infection | No | No | Parietal and ascites CMV fungal sepsis | Cholangitis | No |
| | IPF or PNF | No | No | IPF | No | PNF |
| | IVC thrombosis | No | No | Yes | No | No |
| | Cause of death | — | — | Septic shock MOF | — | PVT; HAT; MOF |
| | Status (mo) | Alive (130) | Alive (109) | Death (2) | Alive (58) | Death (0,5) |
|
|
(GI: gastrointestinal, HA: hepatic artery, HAT: hepatic artery thrombosis, HJ: hepaticojejunostomy, IPF: initial poor function, IS: immunosuppression, PNF: primary nonfunction, PVT: portal vein thrombosis, and TAC: tacrolimus).
|
